Five Versus 2.5 mg/kg of Anti-Thymocyte-Globulin Dose in Reduced-Intensity-Conditioning Reduces Acute and Chronic Graft-Versus-Host Disease for Patients with Myeloid Malignancies Undergoing Allogeneic Stem Cell Transplantation

Autor: Devillier, R., Crocchiolo, R., Castagna, L., Fürst, S., El Cheikh, J., Faucher, C., Prebet, T., Etienne, A., Chabannon, C., Esterni, B., Blaise, D.
Zdroj: In Biology of Blood and Marrow Transplantation 2012 18(2) Supplement:S338-S338
Databáze: ScienceDirect